- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 103.61M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $6.86M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $132.06M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $125.04M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $226.45M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $195.11M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $48.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $61.19M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $58.28M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $71.06M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $215.1M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $184.45M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $284.61M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $266.08M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 94.19M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $702.28K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $3.68M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.20 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.20 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $15.06M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $18.76M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $24.46M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $39.52M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $15.29M |
| Revenue | Q1 2025 · Mar 31, 2024 | $54.81M |